Nemaura Medical Inc.

NMRD · OTC
Analyze with AI
12/31/2023
9/30/2023
6/30/2023
3/31/2023
Operating Activities
Net Income-$2,161-$1,203-$2,603-$4,683
Dep. & Amort.$80$131$98$176
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$176-$466-$561-$369
Other Non-Cash$426-$1,665$545$2,514
Operating Cash Flow-$1,480-$3,203-$2,521-$2,362
Investing Activities
PP&E Inv.-$10-$37-$29-$100
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0-$163
Investing Cash Flow-$10-$37-$29-$100
Financing Activities
Debt Repay.-$3,000$3,922-$3,600-$2,300
Stock Issued$0$0$0$8,393
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0-$737
Financing Cash Flow-$3,000$3,922-$3,600$5,356
Forex Effect$249-$313$55-$130
Net Chg. in Cash-$4,241$369-$6,095$2,764
Supplemental Information
Beg. Cash$4,378$4,010$10,105$7,341
End Cash$137$4,378$4,010$10,105
Free Cash Flow-$1,490-$3,240-$2,551-$2,462